Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$274M |
| 2 |
FRLG
Large Cap Growth Index-Linked Exchange Traded Notes due 2028
FRLG
|
+$138M |
| 3 |
FIHD
UBS AG FI Enhanced Global High Yield ETN
FIHD
|
+$69.1M |
| 4 |
Lumentum
LITE
|
+$41.9M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$41.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$171M |
| 2 |
Petrobras
PBR
|
+$64.7M |
| 3 |
Vale
VALE
|
+$62.7M |
| 4 |
WMGI
Wright Medical Group Inc
WMGI
|
+$61.9M |
| 5 |
HDFC Bank
HDB
|
+$57.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.83% |
| 2 | Financials | 13.08% |
| 3 | Healthcare | 10.74% |
| 4 | Consumer Discretionary | 8.75% |
| 5 | Energy | 5.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Cactus
WHD
$5.12B
| $5.28M | 0.01% |
153,825
-98,745
| -39% | -$3M |
|
352
Philip Morris
PM
$292B
| $5.18M | 0.01% |
60,878
-44,233
| -42% | -$3.65M |
|
353
iShares Europe ETF
IEV
$1.67B
| $5.15M | 0.01% |
109,688
-5,725
| -5% | -$257K |
|
354
iShares ESG Aware USD Corporate Bond ETF
SUSC
$1.29B
| $5.1M | 0.01% |
192,753
+43,682
| +29% | +$1.15M |
|
355
KraneShares CSI China Internet ETF
KWEB
$5.69B
| $5.03M | 0.01% |
103,257
+91,225
| +758% | +$4.17M |
|
356
Vertex Pharmaceuticals
VRTX
$119B
| $4.89M | ﹤0.01% |
22,353
+228
| +1% | +$46.1K |
|
357
Builders FirstSource
BLDR
$7.8B
| $4.79M | ﹤0.01% |
188,631
-1,380
| -0.7% | -$33K |
|
358
Invesco China Technology ETF
CQQQ
$3.05B
| $4.77M | ﹤0.01% |
90,747
-936
| -1% | -$46.2K |
|
359
WisdomTree
WT
$3.21B
| $4.75M | ﹤0.01% |
981,088
| – | – |
|
360
Synopsys
SNPS
$75.1B
| $4.66M | ﹤0.01% |
33,490
-142,558
| -81% | -$19.6M |
|
361
Fidelity National Information Services
FIS
$23.1B
| $4.63M | ﹤0.01% |
33,267
-109,979
| -77% | -$14.7M |
|
|
DASTY
362
DELISTED
DASSAULT SYSTEMES SA ADR
DASTY
| $4.62M | ﹤0.01% |
28,065
-8,002
| -22% | -$1.32M |
|
363
Coca-Cola
KO
$374B
| $4.54M | ﹤0.01% |
82,040
+9,734
| +13% | +$523K |
|
|
KYO
364
DELISTED
Kyocera Adr
KYO
| $4.53M | ﹤0.01% |
65,839
-2,906
| -4% | -$200K |
|
365
8x8 Inc
EGHT
$292M
| $4.51M | ﹤0.01% |
246,616
-212,323
| -46% | -$4.1M |
|
366
Sarepta Therapeutics
SRPT
$1.68B
| $4.42M | ﹤0.01% |
34,226
-1,915
| -5% | -$193K |
|
367
AT&T
T
$162B
| $4.19M | ﹤0.01% |
142,020
+22,762
| +19% | +$657K |
|
368
Rexford Industrial Realty
REXR
$8.4B
| $4.18M | ﹤0.01% |
91,435
-19,902
| -18% | -$920K |
|
369
iShares Global Healthcare ETF
IXJ
$4.08B
| $4.17M | ﹤0.01% |
60,646
-3,235
| -5% | -$210K |
|
|
LHCG
370
DELISTED
LHC Group LLC
LHCG
| $4.14M | ﹤0.01% |
30,029
-1,514
| -5% | -$188K |
|
371
iShares Global Industrials ETF
EXI
$1.45B
| $4.05M | ﹤0.01% |
41,609
+29,327
| +239% | +$2.79M |
|
372
Incyte
INCY
$24B
| $4.02M | ﹤0.01% |
45,994
+17,304
| +60% | +$1.48M |
|
|
WLH
373
DELISTED
WILLIAM LYON HOMES
WLH
| $3.99M | ﹤0.01% |
199,919
-15,788
| -7% | -$323K |
|
374
Kimberly-Clark
KMB
$35.7B
| $3.84M | ﹤0.01% |
27,945
+460
| +2% | +$62.2K |
|
375
Hexcel
HXL
$7.73B
| $3.83M | ﹤0.01% |
52,171
+16,606
| +47% | +$1.28M |
|
Similar funds
Ken Fisher's Q4 2019 Portfolio in Review
As of Q4 2019, Ken Fisher held 981 positions worth $99B, up 8.6% from $91.1B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Fisher's Q4 2019 filing shows 78 new, 256 increased, 457 reduced and 83 closed positions. Its largest new stake was Enterprise Products Partners: 584,777 shares worth $16.5M. The largest sale was TSMC, an estimated $171M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Ken Fisher's largest Q4 2019 buy was Enterprise Products Partners: 584,777 shares worth $16.5M.
- Ken Fisher added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2019, an estimated $274M increase.
- Ken Fisher's biggest Q4 2019 reduction was TSMC, cutting an estimated $171M.
- Ken Fisher fully exited Wright Medical Group Inc in Q4 2019, selling an estimated $61.9M.
- Ken Fisher's ten largest holdings make up 28% of its $99B portfolio in Q4 2019.
- Ken Fisher opened 78 new positions and closed 83 in Q4 2019.
- Ken Fisher's portfolio value rose 8.6% quarter-over-quarter to $99B.
Based on Fisher Asset Management's 13F filing for Q4 2019, filed 12 Feb 2020.